Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · Real-Time Price · USD
38.64
-1.84 (-4.55%)
At close: Apr 1, 2025, 4:00 PM
38.00
-0.64 (-1.66%)
After-hours: Apr 1, 2025, 7:37 PM EDT

Akero Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Market Capitalization
3,0771,9421,3012,563738896
Upgrade
Market Cap Growth
49.28%49.28%-49.24%247.29%-17.63%41.33%
Upgrade
Enterprise Value
2,3151,1917142,199524606
Upgrade
Last Close Price
38.6427.8223.3554.8021.1525.80
Upgrade
PB Ratio
3.732.592.437.854.363.46
Upgrade
P/TBV Ratio
2.592.592.437.854.363.46
Upgrade
Debt / Equity Ratio
0.050.050.050.030.010.01
Upgrade
Quick Ratio
18.6918.6928.7518.427.4920.47
Upgrade
Current Ratio
19.3819.3829.2718.617.7020.70
Upgrade
Return on Equity (ROE)
-39.22%-39.22%-35.22%-45.20%-47.11%-40.89%
Upgrade
Return on Assets (ROA)
-25.37%-25.37%-23.06%-26.07%-26.90%-24.35%
Upgrade
Return on Capital (ROIC)
-26.47%-26.47%-24.03%-28.33%-29.25%-25.73%
Upgrade
Earnings Yield
-8.19%-12.98%-11.67%-4.37%-13.66%-8.84%
Upgrade
FCF Yield
-7.51%-11.90%-11.18%-3.61%-10.80%-7.92%
Upgrade
Buyback Yield / Dilution
-27.71%-27.71%-34.84%-11.94%-10.69%-108.77%
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q